Twitter YesterdayFrom Twitter yesterday:
CEO, Andrew Schutte and Chief Science Officer, Kevin McElwee attended the European Hair Research Society Biannual Conference in Sheffield, UK! Great connections and progress towards developing RCH-01 for Androgenetic Alopecia. We received a lot of interest in our functional commercial grade Dermaprecise injector. Thank you to the EHRS organizers for a fantastic event, many of whom we are collaborating with.
"Functional commercial grade Dermaprecise Injector". That is an encouraging comment. Not sure if that means it is at the point where it can be submitted for FDA Approval. It would be nice to know.